You have 9 free searches left this month | for more free features.

City

Moscow (1)

Condition

COVID-19 (1)

Mild to Moderate (1)

Overall Status

Completed (1)

Sign in for free

Phase

Sponsor

Pirogov Russian National Research Medical University (1)

Collaborator

City Clinical Hospital No.52 of Moscow Healthcare Department (1)

Intervention

baricitinib oral tablet (1)

netakimab (1)

standard of care therapy (1)

tocilizumab injection (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Observational (1)

netakimab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Russian Clinical and Research Center of Gerontology of Pirogov

Completed

COVID-19
Mild to Moderate

Baricitinib Oral Tablet
+3 more

Moscow, Russian Federation
+1 more

Mar 31, 2022